Drug: Actos
2006 sales: $3.05 billion
Manufacturer: Takeda
Safety concern: “black box;†heart failure
Related Articles:
> Takeda touts Actos as heart attack-free. Report [1]
> Actos on a good-news roll. Report [2]
> Actos study points to reduction in heart attacks, strokes. Report [3]
> Diabetes drug helps reduce rate of strokes. Report [4]
> Avandia, Actos don't boost death risk. Report [5]
Links:
[1] http://www.fiercepharma.com/story/takeda-touts-actos-heart-attack-free/2007-11-16
[2] http://www.fiercepharma.com/story/actos-good-news-roll/2007-09-21
[3] http://www.fiercebiotech.com/story/actos-study-points-to-reduction-in-heart-attacks-strokes/2005-09-12
[4] http://www.fiercebiotech.com/story/diabetes-drug-helps-reduce-rate-of-strokes/2006-09-05
[5] http://www.fiercepharma.com/story/avandia-actos-dont-boost-death-risk/2007-09-28
[6] http://www.fiercepharma.com/special-reports/4-avandia-top-10-warnings-and-recalls
[7] http://www.fiercepharma.com/special-reports/top-10-drug-warnings-and-recalls-2007
[8] http://www.fiercepharma.com/special-reports/6-provigil-top-10-warnings-and-recalls